Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

88 results

Filters applied: . Clear all
Page 1
Long-term outcomes of multidisciplinary treatment combining surgery and stereotactic radiotherapy with Novalis for craniopharyngioma.
Shinojima N, Yano S, Uchida D, Mizukami N, Mabe H, Kawashima J, Igata M, Kondo T, Uetani H, Yamamoto T, Uekawa K, Hide T, Mikami Y, Hirai T, Mukasa A. Shinojima N, et al. Among authors: yano s. J Clin Neurosci. 2024 Feb;120:138-146. doi: 10.1016/j.jocn.2024.01.002. Epub 2024 Jan 19. J Clin Neurosci. 2024. PMID: 38244528
The purpose of this study is to retrospectively evaluate the long-term efficacy and adverse events of stereotactic radiotherapy (SRT) with Novalis for craniopharyngioma. ...No delayed adverse events such as brain necrosis, cerebral artery stenosis, cerebral infarction, or …
The purpose of this study is to retrospectively evaluate the long-term efficacy and adverse events of stereotactic radiotherapy (SRT) …
Atomic reconstruction induced by uniaxial stress in MnP.
Kozawa T, Fujihala M, Uchihara T, Mitsuda S, Yano SI, Tamatsukuri H, Munakata K, Nakao A. Kozawa T, et al. Among authors: yano si. Sci Rep. 2023 Aug 23;13(1):13750. doi: 10.1038/s41598-023-40806-1. Sci Rep. 2023. PMID: 37612384 Free PMC article.
The structure of the coexisting domains accounts for the stress-induced magnetism. We term this first discovered phenomenon atomic reconstruction (AR) induced by uniaxial stress. ...
The structure of the coexisting domains accounts for the stress-induced magnetism. We term this first discovered phenomenon atomic re …
Transgastric Jejunostomy (PEG-J) for Continuous Infusion of Levodopa-Carbidopa Intestinal Gel: An Approach for Parkinson's Disease Treatment.
Nomoto Y, Furihata M, Hagiwara H, Ishino H, Yano S, Okawa H, Nakatsu Y, Noda K, Nishi S, Ogiwara S, Kitamura T, Osada T. Nomoto Y, et al. Among authors: yano s. Med Sci Monit. 2023 Aug 12;29:e941285. doi: 10.12659/MSM.941285. Med Sci Monit. 2023. PMID: 37571821 Free PMC article.
BACKGROUND Parkinson's disease (PD) is a neurodegenerative disorder that often requires long-term management of motor symptoms. Continuous infusion of levodopa-carbidopa intestinal gel (LCIG) has shown promising results in alleviating motor fluctuations and improving quali …
BACKGROUND Parkinson's disease (PD) is a neurodegenerative disorder that often requires long-term management of motor symptoms. Conti …
PD-L1-negative Non-small-cell Lung Cancer Treated with Nivolumab Plus Ipilimumab during Maintenance Hemodialysis Results in Rapid Initial Progression Followed by a Long-lasting Response.
Yano S, Uematsu S, Kunimune N, Harima T, Yoshida Y, Takahashi S, Ito M, Sakamoto H, Nishizaka Y. Yano S, et al. Intern Med. 2024 Apr 1;63(7):985-988. doi: 10.2169/internalmedicine.2270-23. Epub 2023 Aug 9. Intern Med. 2024. PMID: 37558475 Free PMC article.
We observed general deterioration and enlarged lesions, followed by a long-term response. The patient developed secondary hypoadrenocorticism, an immune-related adverse event that was easily controlled. Nivolumab plus ipilimumab can be used safely for patients with NSCLC o …
We observed general deterioration and enlarged lesions, followed by a long-term response. The patient developed secondary hypoadrenoc …
Association of functional and cognitive impairment severity with discharge to long-term care facilities in older patients admitted to a general acute care hospital from home.
Mitsutake S, Yano S, Ishizaki T, Furuta K, Hatakeyama A, Sugiyama M, Awata S, Ito H, Toba K. Mitsutake S, et al. Among authors: yano s. Arch Gerontol Geriatr. 2023 Dec;115:105111. doi: 10.1016/j.archger.2023.105111. Epub 2023 Jun 26. Arch Gerontol Geriatr. 2023. PMID: 37421690
BACKGROUND: The early recognition of hospitalized patients at risk of being discharged to long-term care facilities (LTCFs) may help to identify those who require transitional care programs and interventions that support discharge to home. ...
BACKGROUND: The early recognition of hospitalized patients at risk of being discharged to long-term care facilities (LTCFs) may help …
Allogeneic Hematopoietic Cell Transplantation for Patients with Relapsed Acute Promyelocytic Leukemia.
Yanada M, Matsuda K, Ishii H, Fukuda T, Ozeki K, Ota S, Tashiro H, Uchida N, Kako S, Doki N, Kawakita T, Onishi Y, Takada S, Kondo Y, Tanaka J, Kanda Y, Atsuta Y, Yano S. Yanada M, et al. Among authors: yano s. Transplant Cell Ther. 2022 Dec;28(12):847.e1-847.e8. doi: 10.1016/j.jtct.2022.09.021. Epub 2022 Sep 28. Transplant Cell Ther. 2022. PMID: 36179987 Free article.
In the patients who had relapsed after prior autologous HCT, the 5-year OS rate was 47% for those who underwent allogeneic HCT in CR and 6% for those who did so in non-CR (P = .001). Allogeneic HCT still provides an opportunity for long-term survival for certain patients w …
In the patients who had relapsed after prior autologous HCT, the 5-year OS rate was 47% for those who underwent allogeneic HCT in CR and 6% …
Pan-HER inhibitors overcome lorlatinib resistance caused by NRG1/HER3 activation in ALK-rearranged lung cancer.
Taniguchi H, Akagi K, Dotsu Y, Yamada T, Ono S, Imamura E, Gyotoku H, Takemoto S, Yamaguchi H, Sen T, Yano S, Mukae H. Taniguchi H, et al. Among authors: yano s. Cancer Sci. 2023 Jan;114(1):164-173. doi: 10.1111/cas.15579. Epub 2022 Sep 21. Cancer Sci. 2023. PMID: 36086904 Free PMC article.
We established two different lorlatinib-resistant ALK-rearranged lung cancer cell lines (H3122LR and A925LLR) via long-term administration of lorlatinib. These resistant cells did not harbor the secondary ALK mutations and showed cross-resistance to the other kinds of ALK- …
We established two different lorlatinib-resistant ALK-rearranged lung cancer cell lines (H3122LR and A925LLR) via long-term administr …
Genome-Wide RNA Sequencing Analysis in Human Dermal Fibroblasts Exposed to Low-Dose Ultraviolet A Radiation.
Wang J, Yano S, Xie K, Ohata Y, Hara T. Wang J, et al. Among authors: yano s. Genes (Basel). 2022 May 29;13(6):974. doi: 10.3390/genes13060974. Genes (Basel). 2022. PMID: 35741736 Free PMC article.
High-dose UVA exposure induces erythema, whereas low-dose, long-term UVA exposure causes skin damage and cell senescence. Biomarkers for evaluating damage caused by low-dose UVA in fibroblasts are lacking, making it difficult to develop therapeutic agents for skin aging an …
High-dose UVA exposure induces erythema, whereas low-dose, long-term UVA exposure causes skin damage and cell senescence. Biomarkers …
Deficiency of the splicing factor RBM10 limits EGFR inhibitor response in EGFR-mutant lung cancer.
Nanjo S, Wu W, Karachaliou N, Blakely CM, Suzuki J, Chou YT, Ali SM, Kerr DL, Olivas VR, Shue J, Rotow J, Mayekar MK, Haderk F, Chatterjee N, Urisman A, Yeo JC, Skanderup AJ, Tan AC, Tam WL, Arrieta O, Hosomichi K, Nishiyama A, Yano S, Kirichok Y, Tan DS, Rosell R, Okimoto RA, Bivona TG. Nanjo S, et al. Among authors: yano s. J Clin Invest. 2022 Jul 1;132(13):e145099. doi: 10.1172/JCI145099. J Clin Invest. 2022. PMID: 35579943 Free PMC article.
Molecularly targeted cancer therapy has improved outcomes for patients with cancer with targetable oncoproteins, such as mutant EGFR in lung cancer. Yet, the long-term survival of these patients remains limited, because treatment responses are typically incomplete. ...
Molecularly targeted cancer therapy has improved outcomes for patients with cancer with targetable oncoproteins, such as mutant EGFR in lung …
88 results